Treating neuropathic/inflammatory pain by targeting a composition (e.g.ZD7288) to HCN pacemaker channels

Details for Australian Patent Application No. 2002305738 (hide)

Owner Ortho-McNeil Pharmaceutical, Inc. The Regents of the University of California

Inventors Lee, Doo Hyun; Chaplan, Sandra; Dubin, Adrienne; Liu, Changlu

Agent Shelston IP

Pub. Number AU-B-2002305738

PCT Number PCT/US02/16910

PCT Pub. Number WO2002/100408

Priority 60/347,945 07.11.01 US; 60/373,012 16.04.02 US; 60/297,108 08.06.01 US

Filing date 30 May 2002

Wipo publication date 23 December 2002

Acceptance publication date 20 September 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/195 (2006.01)

A61K 31/197 (2006.01)

A61K 31/4166 (2006.01)

A61K 31/4168 (2006.01)

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 49/00 (2006.01) Preparations for testing

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/347,945 07.11.01 US; 60/373,012 16.04.02 US; 60/297,108 08.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002305738

20 September 2007 Application Accepted

  Published as AU-B-2002305738

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002305739-METHOD AND SYSTEM FOR AUTOMATICALLY CONFIGURING A CLIENT-SERVER NETWORK

2002305737-Taste-masking of highly water-soluble drugs